A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

by | Jan 22, 2026 | Clinical Trials | 0 comments

​ Conditions: Refractory Metastatic Colorectal Cancer

Interventions: Drug: Suvemcitug injection, trifluridine/tipiracil tablets; Drug: Suvemcitug placebo injection, trifluridine/tipiracil tablets

Sponsors: Jiangsu Simcere Pharmaceutical Co., Ltd.; Jiangsu Simcere Biologics Co., Ltd

Recruiting Conditions: Refractory Metastatic Colorectal Cancer
Interventions: Drug: Suvemcitug injection, trifluridine/tipiracil tablets; Drug: Suvemcitug placebo injection, trifluridine/tipiracil tablets
Sponsors: Jiangsu Simcere Pharmaceutical Co., Ltd.; Jiangsu Simcere Biologics Co., Ltd
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *